|
US4812462A
(en)
|
1986-04-01 |
1989-03-14 |
Warner-Lambert Company |
4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
|
|
US4816463A
(en)
|
1986-04-01 |
1989-03-28 |
Warner-Lambert Company |
Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
|
|
CA2093125C
(en)
|
1990-10-02 |
2003-12-16 |
Warner-Lambert Company |
Angiotensin ii antagonists
|
|
CA2493637A1
(en)
|
2002-07-25 |
2004-02-12 |
Manuela Villa |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
EP1526852A1
(en)
|
2002-07-25 |
2005-05-04 |
Pharmacia Italia S.p.A. |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
GB0312609D0
(en)
|
2003-06-02 |
2003-07-09 |
Astrazeneca Ab |
Novel compounds
|
|
AR045037A1
(es)
|
2003-07-10 |
2005-10-12 |
Aventis Pharma Sa |
Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
|
|
FR2857363B1
(fr)
|
2003-07-10 |
2007-09-07 |
Aventis Pharma Sa |
4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
|
|
EP1784188B1
(en)
|
2004-08-23 |
2010-07-14 |
Merck Sharp & Dohme Corp. |
Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
WO2006080884A1
(en)
|
2005-01-27 |
2006-08-03 |
Astrazeneca Ab |
Novel biaromatic compounds, inhibitors of the p2x7-receptor
|
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
|
WO2006110516A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
Acylhydrazide p2x7 antagonists and uses thereof
|
|
US7943617B2
(en)
|
2006-11-27 |
2011-05-17 |
Bristol-Myers Squibb Company |
Heterobicyclic compounds useful as kinase inhibitors
|
|
FR2915197B1
(fr)
|
2007-04-18 |
2009-06-12 |
Sanofi Aventis Sa |
Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
|
|
KR20100023040A
(ko)
|
2007-06-21 |
2010-03-03 |
쉐링 코포레이션 |
폴리사이클릭 구아닌 유도체 및 이의 용도
|
|
CA2691512A1
(en)
|
2007-08-10 |
2009-02-19 |
H. Lundbeck A/S |
Heteroaryl amide analogues
|
|
FR2921342B1
(fr)
|
2007-09-20 |
2010-03-12 |
Airbus France |
Carenage aerodynamique arriere inferieur pour dispositif d'accrochage d'un moteur d'aeronef
|
|
EP2090576A1
(en)
|
2008-02-01 |
2009-08-19 |
Merz Pharma GmbH & Co.KGaA |
6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
|
|
KR101598397B1
(ko)
|
2008-04-22 |
2016-02-29 |
얀센 파마슈티카 엔.브이. |
퀴놀린 또는 이소퀴놀린 치환된 피2엑스7 안타고니스트
|
|
JP5063815B2
(ja)
|
2008-11-25 |
2012-10-31 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
抗腫瘍および抗神経変性剤としての二環式ピラゾールおよびイソオキサゾール誘導体
|
|
WO2010066629A2
(en)
|
2008-12-09 |
2010-06-17 |
F. Hoffmann-La Roche Ag |
Novel azaindoles
|
|
JP5654001B2
(ja)
|
2009-04-29 |
2015-01-14 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
Ｐ２Ｘ７調節因子としての５，６，７，８−テトラヒドロ［１，２，４］トリアゾロ［４，３−ａ］ピラジン誘導体
|
|
GB0907515D0
(en)
|
2009-04-30 |
2009-06-10 |
Glaxo Group Ltd |
Compounds
|
|
US8871760B2
(en)
|
2009-09-21 |
2014-10-28 |
Roche Palo Alto Llc |
[1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
|
|
WO2011050202A1
(en)
|
2009-10-23 |
2011-04-28 |
Janssen Pharmaceutica Nv |
Fused heterocyclic compounds as orexin receptor modulators
|
|
WO2011103715A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Task channel antagonists
|
|
PL2552920T3
(pl)
|
2010-04-02 |
2017-08-31 |
Ogeda Sa |
Nowe wybiórcze związki antagonistów receptora NK-3, farmaceutyczne kompozycje i sposoby do zastosowania w zaburzeniach pośredniczonych przez receptory NK-3
|
|
EP2558661A4
(en)
|
2010-04-16 |
2014-10-29 |
Fernandez Rodrigo Graf |
FOLDABLE STRUCTURES FOR CONSTRUCTION
|
|
EP2619204A4
(en)
|
2010-09-21 |
2014-08-27 |
Merck Sharp & Dohme |
TRIAZOLOPYRAZINONE AS P2X7 RECEPTOR ANTAGONISTS
|
|
BR112013009828A2
(pt)
|
2010-10-22 |
2016-07-26 |
Janssen Pharmaceutica Nv |
diamidas de amino-pirrolidina-azetidina como inibidores de monoacilglicerol lipase
|
|
JP2013540159A
(ja)
|
2010-10-22 |
2013-10-31 |
ヤンセン ファーマシューティカ エヌ．ベー． |
モノアシルグリセロールリパーゼ阻害剤としてのピペリジン−４−イル−アゼチジンジアミド
|
|
WO2012145581A1
(en)
|
2011-04-20 |
2012-10-26 |
Janssen Pharmaceutica Nv |
Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
|
|
WO2013055984A1
(en)
*
|
2011-10-14 |
2013-04-18 |
Bristol-Myers Squibb Company |
Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
|
|
US9273947B2
(en)
|
2012-02-07 |
2016-03-01 |
Lg Innotek Co., Ltd. |
Sensing magnet apparatus for motor
|
|
US9056874B2
(en)
|
2012-05-04 |
2015-06-16 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
SG11201408284VA
(en)
|
2012-05-22 |
2015-02-27 |
Xenon Pharmaceuticals Inc |
N-substituted benzamides and their use in the treatment of pain
|
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
JO3459B1
(ar)
|
2012-09-09 |
2020-07-05 |
H Lundbeck As |
تركيبات صيدلانية لعلاج مرض الزهايمر
|
|
PE20150887A1
(es)
|
2012-10-15 |
2015-06-04 |
Epizyme Inc |
Compuestos de benceno sustituidos
|
|
US9290476B2
(en)
|
2012-10-16 |
2016-03-22 |
Janssen Pharmaceutica Nv |
Methylene linked quinolinyl modulators of RORγt
|
|
TWI646099B
(zh)
|
2012-11-01 |
2019-01-01 |
英塞特控股公司 |
作爲ｊａｋ抑制劑之三環稠合噻吩衍生物
|
|
US9796729B2
(en)
|
2012-11-23 |
2017-10-24 |
Glaxosmithkline Llc |
Compounds as diacylglycerol acyltransferase inhibitors
|
|
MX365640B
(es)
|
2012-12-21 |
2019-06-10 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de quinasas y sus indicaciones.
|
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
BR112015014968A2
(pt)
|
2012-12-21 |
2017-07-11 |
Quanticel Pharmaceuticals Inc |
inibidores de histona-desmetilase
|
|
MX2015009952A
(es)
|
2013-02-08 |
2015-10-05 |
Celgene Avilomics Res Inc |
Inhibidores de cinasas reguladas por señales extracelulares (erk) y sus usos.
|
|
NO335177B1
(no)
|
2013-03-06 |
2014-10-13 |
Cambi Technology As |
Fremgangsmåte og anordning for termisk biologisk nedbryting og avvanning av biomasse
|
|
SMT202000084T1
(it)
|
2013-03-06 |
2020-03-13 |
Janssen Pharmaceutica Nv |
Modulatori benzoimidazol-2-il pirimidinici del recettore h4 dell'istamina
|
|
JO3509B1
(ar)
|
2013-03-14 |
2020-07-05 |
Janssen Pharmaceutica Nv |
معدلات p2x7
|
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
JO3383B1
(ar)
|
2013-03-14 |
2019-03-13 |
Lilly Co Eli |
مثبطات cdc7
|
|
TWI644671B
(zh)
|
2013-03-14 |
2018-12-21 |
比利時商健生藥品公司 |
Ｐ２ｘ７調節劑
|
|
US9604982B2
(en)
|
2013-03-14 |
2017-03-28 |
Janssen Pharmaceutica Nv |
P2X7 modulators
|
|
KR20150126623A
(ko)
|
2013-03-14 |
2015-11-12 |
뉴링크 제네틱스 코퍼레이션 |
트립토판 대사로 인한 면역억제의 억제제로서의 삼환식 화합물
|
|
US9040534B2
(en)
|
2013-03-14 |
2015-05-26 |
Janssen Pharmaceutica Nv |
[1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators
|
|
SG11201507395PA
(en)
|
2013-03-14 |
2015-10-29 |
Curadev Pharma Private Ltd |
Inhibitors of the kynurenine pathway
|
|
ES2845473T3
(es)
|
2013-03-14 |
2021-07-26 |
Boehringer Ingelheim Int |
(Bencil-ciano-metil)-amidas sustituidas de ácido 2-aza-biciclo[2.2.1]heptano-3-carboxílico inhibidores de la catepsina- C
|
|
HUE043568T2
(hu)
|
2013-03-14 |
2019-08-28 |
Glaxosmithkline Ip No 2 Ltd |
2,3-diszubsztituált 1-acil-4-amino-1,2,3,4-tetrahidrokinolin származékok és bromodomén inhibitorokkénti felhasználásuk
|
|
CA2907814C
(en)
|
2013-03-29 |
2021-07-13 |
Euroscreen Sa |
Novel n-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor-mediated disorders
|
|
CN105658639A
(zh)
|
2013-08-22 |
2016-06-08 |
豪夫迈·罗氏有限公司 |
炔基醇和应用方法
|
|
KR102455043B1
(ko)
|
2014-09-11 |
2022-10-13 |
얀센 파마슈티카 엔.브이. |
치환된 2-아자바이사이클 및 오렉신 수용체 조절제로서의 이의 용도
|
|
WO2016039977A1
(en)
|
2014-09-12 |
2016-03-17 |
Janssen Pharmaceutica Nv |
P2x7 modulators
|
|
AU2015315693B2
(en)
|
2014-09-12 |
2020-01-16 |
Janssen Pharmaceutica Nv |
P2X7 modulating n-acyl-triazolopyrazines
|
|
JP6653319B2
(ja)
|
2015-03-30 |
2020-02-26 |
武田薬品工業株式会社 |
複素環化合物
|
|
WO2017087858A1
(en)
|
2015-11-20 |
2017-05-26 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
|
EP3571202B1
(en)
|
2017-01-23 |
2021-06-30 |
Pfizer Inc. |
Heterocyclic spiro compounds as magl inhibitors
|
|
MY205440A
(en)
|
2018-09-28 |
2024-10-21 |
Janssen Pharmaceutica Nv |
Monoacylglycerol lipase modulators
|
|
KR20210069079A
(ko)
|
2018-09-28 |
2021-06-10 |
얀센 파마슈티카 엔.브이. |
모노아실글리세롤 리파아제 조절제
|
|
CN112272670B
(zh)
|
2019-04-16 |
2023-12-12 |
上海翰森生物医药科技有限公司 |
含二并环类衍生物抑制剂、其制备方法和应用
|
|
JP7697934B2
(ja)
|
2019-09-30 |
2025-06-24 |
ヤンセン ファーマシューティカ エヌ．ベー． |
放射線標識されたｍｇｌ ｐｅｔリガンド
|
|
BR112022019077A2
(pt)
|
2020-03-26 |
2022-12-27 |
Janssen Pharmaceutica Nv |
Moduladores da monoacilglicerol lipase
|